tiprankstipranks
Bicara Therapeutics Inc. (BCAX)
NASDAQ:BCAX
US Market

Bicara Therapeutics Inc. (BCAX) Income Statement

Compare
28 Followers

Bicara Therapeutics Inc. Income Statement

Last quarter (Q3 2024), Bicara Therapeutics Inc.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Bicara Therapeutics Inc.'s net income was $-17.48M. See Bicara Therapeutics Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22
Total Revenue
$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00
Operating Expenses
$ 39.89M$ 37.66M
Depreciation and Amortization
$ 19.00K$ 10.00K
EBITDA
$ -51.96M$ -37.72M
Operating Income
$ -39.89M$ -37.66M
Other Income/Expenses
$ -12.09M$ -188.00K
Pretax Income
$ -51.98M$ -37.84M
Net Income
$ -51.98M$ -37.84M
Per Share Metrics
$ ―$ ―
Basic EPS
$ -1.00$ -2.45
Diluted EPS
$ -1.00$ -2.45
Weighted Average Shares Outstanding
51.76M 15.44M
Weighted Average Shares Outstanding (Diluted)
51.76M 15.44M
Currency in USD

Bicara Therapeutics Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis